The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, K. C.
Right arrow Articles by Nadler, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, K. C.
Right arrow Articles by Nadler, L. M.

The Journal of Immunology, Vol 130, Issue 3 1132-1138, Copyright © 1983 by American Association of Immunologists


ARTICLES

Antigens on human plasma cells identified by monoclonal antibodies

KC Anderson, EK Park, MP Bates, RC Leonard, R Hardy, SF Schlossman and LM Nadler

Two monoclonal antibodies that define distinct plasma cell-associated antigens, termed PCA-1 and PCA-2, were developed against human plasma cell leukemia cells. These antigens are strongly expressed on human myelomas, plasma cell leukemia, and plasmacytoma tumor cells, but are not detected on other lymphoid malignancies of B, T, null, or myeloid origin. PCA-1 and PCA-2 are not expressed on either normal T or B lymphocytes, but are weakly expressed on granulocytes and monocytes. When pokeweed mitogen is used to induce human B lymphocyte differentiation, PCA-1 is expressed when other B cell determinants are lost and plasmacytoid morphology, intracytoplasmic immunoglobulins, and surface T10 staining characteristic of plasma cells appear. In contrast, PCA-2 cannot be induced and may therefore appear later in the B cell differentiation scheme. These antigens may be of utility for the study and regulation of normal and abnormal plasma cell growth, traffic, and tissue distribution and may aid in understanding heterogeneity within plasma cell dyscrasias.


This article has been cited by other articles:


Home page
BloodHome page
S. Ozaki, M. Kosaka, Y. Wakahara, Y. Ozaki, M. Tsuchiya, Y. Koishihara, T. Goto, and T. Matsumoto
Humanized Anti-HM1.24 Antibody Mediates Myeloma Cell Cytotoxicity That Is Enhanced by Cytokine Stimulation of Effector Cells
Blood, June 1, 1999; 93(11): 3922 - 3930.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Ozaki, M. Kosaka, S. Wakatsuki, M. Abe, Y. Koishihara, and T. Matsumoto
Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24
Blood, October 15, 1997; 90(8): 3179 - 3186.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S Seremetis, G Inghirami, D Ferrero, E. Newcomb, D. Knowles, G. Dotto, and R Dalla-Favera
Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes
Science, February 3, 1989; 243(4891): 660 - 663.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.